Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway
Background: Follistatin-like 1 (FSTL1) is a novel profibrogenic factor that induces pulmonary fibrosis (PF) through the transforming growth factor-beta 1 (TGF-β1)/Smad signaling. Little is known about its effects on PF through the non-Smad signaling, like the mitogen-activated protein kinase (MAPK)...
Main Authors: | Yan-Kun Jin, Xiao-He Li, Wang Wang, Jie Liu, Wei Zhang, Yin-Shan Fang, Zhi-Fei Zhang, Hua-Ping Dai, Wen Ning, Chen Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2018-01-01
|
Series: | Chinese Medical Journal |
Subjects: | |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=16;spage=1917;epage=1925;aulast=Jin |
Similar Items
-
The Mechanism of Action of Follistatin-like Protein-1 (FSTL-1)
by: V. G. Kukes, et al.
Published: (2019-12-01) -
Follistatin-Like 1
by: Kai C. Wollert, MD
Published: (2016-06-01) -
Caveolin-1 regulation of Sp1 controls production of the antifibrotic protein follistatin in kidney mesangial cells
by: Neel Mehta, et al.
Published: (2019-04-01) -
Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway
by: Yinhui Wang, et al.
Published: (2021-07-01) -
Follistatin-Like 1 Regulates Hypertrophy in Heart Failure With Preserved Ejection Fraction
by: Komei Tanaka, MD, PhD, et al.
Published: (2016-06-01)